Hinde El Otmani/ISTH
Oct 16, 2025, 04:37
Hinde El Otmani’s Team Explores Plasmin-Mediated Proteolysis of von Willebrand Factor in Acutely Ill Patients
RPTH Journal shared on LinkedIn:
”Elevated von Willebrand factor (VWF) is common in liver disease, but its regulation remains unclear.
The latest study from Hinde El Otmani explores how plasmin-mediated VWF cleavage may lead to microvascular changes in acutely ill patients.
Check it out here.
Co-authors: Ton Lisman, Coen Maas, Marilena Stamouli, Jelle Adelmeijer”
Read the full article in RPTH.
Article: Plasmin-mediated proteolysis of von Willebrand factor in patients with acute and chronic liver disease
Authors: Hinde El Otmani, Marilena Stamouli, Jelle Adelmeijer, William Bernal, Coen Maas, Vishal C. Patel, Ton Lisman
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Sep 7, 2026, 23:56Abdel Gaffar Mohammed: Treatment Approaches for Different Types of TMA
-
Sep 7, 2026, 18:36Richard Kollen: Preventing Deep Vein Thrombosis During Long Flights
-
Sep 7, 2026, 18:34Mahmoud Hashem: Apixaban – Doses According to the Reason for Use
-
Sep 7, 2026, 18:31Julian P. Villacastin: LAAC as a Treatment Option When Long-Term Anticoagulation Is Problematic
-
Sep 7, 2026, 18:29Geoff Stooke: How Hemophilia Led the Massie Family to the Romanovs and Ronald Reagan
-
Sep 7, 2026, 18:27Sam Mbunya: September is Sickle Cell Awareness Month
-
Sep 7, 2026, 18:25David Akande: Things I Wish People Knew About Sickle Cell
-
Sep 7, 2026, 18:24Prachi Bansal: A Small Act of Giving, A Lifelong Lesson in Humanity
-
Sep 7, 2026, 17:27Isaac Okello: From Global Dialogue to Local Impact in Sickle Cell Disease